Wound care clinicians operate in one of medicine’s most demanding regulatory environments. You’re treating patients with complex, chronic wounds: diabetic foot ulcers that have persisted for months, venous leg ulcers complicated by lymphedema, pressure injuries in patients with a dozen comorbidities. Then you’re measured by quality metrics designed for primary care. The result is penalty exposure that doesn’t reflect your clinical reality, and outcomes data that can’t defend your specialty when CMS comes calling.
Clinical data registries exist to fix exactly that problem. Unlike administrative claims data or generic EHR exports, a well-designed registry captures the clinical granularity that makes wound care outcomes meaningful: wound etiology, depth, infection status, comorbidity burden, prior treatment history. When that data is aggregated across thousands of patients and risk-adjusted, it becomes something genuinely powerful — a defensible record of what wound care actually achieves in the real world.
For wound care specialists, podiatrists, hyperbaric physicians, and the administrators who support them, registry participation isn’t a compliance checkbox. It’s a strategic asset. The seven strategies below outline how to extract maximum value from clinical data registry participation — from surviving MIPS to defending your specialty against coverage cuts to generating the real-world evidence that device and drug manufacturers can’t get from clinical trials.
1. Replace Generic MIPS Measures With Specialty-Specific QCDR Measures
The Challenge It Solves
Standard MIPS measures were built for primary care and chronic disease management. When wound care specialists, podiatrists, and hyperbaric physicians attempt to report through the general measure set, they often find few applicable measures and face a structural scoring disadvantage. The Alliance of Wound Care Stakeholders has raised this concern in public comment periods, and it reflects a real gap in how the Quality Payment Program was designed.
The Strategy Explained
CMS created Qualified Clinical Data Registries (QCDRs) specifically to allow specialty organizations to submit non-MIPS measures that better reflect their patient populations. As a CMS-approved QCDR, the US Wound & Podiatry Registries enables wound care clinicians to report on wound care-specific quality measures: healing trajectories, wound etiology-specific endpoints, and risk-adjusted performance benchmarks that account for the complexity of the patients you actually treat.
This isn’t just a workaround. It’s the mechanism CMS built to make specialty reporting equitable. Participating through a QCDR means your MIPS score reflects wound care clinical reality rather than primary care assumptions.
Implementation Steps
1. Confirm your current MIPS reporting pathway and identify which measures you’re submitting. Note any measures where your patient population makes performance difficult or impossible to optimize.
2. Review the CMS-published QCDR list (available at https://qpp.cms.gov/) to verify registry approval status, then evaluate whether the registry’s wound care-specific measures align with your practice’s case mix.
3. Enroll in a CMS-approved wound care QCDR before the performance year reporting deadline, and work with the registry’s support team to map your existing clinical documentation to required data elements.
Pro Tips
Don’t wait until Q4 to evaluate your MIPS pathway. QCDR enrollment decisions made early in the performance year give your practice time to build complete data submissions rather than scrambling to document retrospectively. The practices that consistently avoid penalties are the ones that treat registry enrollment as an operational priority, not an afterthought.
2. Protect High-Complexity Practices Through Risk Adjustment
The Challenge It Solves
Raw outcome rates are inherently misleading when your patients arrive with six comorbidities and wounds that have been present for six months or longer. A wound center treating predominantly diabetic foot ulcers complicated by peripheral arterial disease and renal failure will show different healing rates than a practice seeing acute post-surgical wounds — not because care is worse, but because the patient population is fundamentally different. Without risk adjustment, complex practices absorb quality penalties they haven’t earned.
The Strategy Explained
Registry-based risk adjustment benchmarks your performance against comparable patient populations rather than against an undifferentiated national average. Wound care patients disproportionately present with diabetes, peripheral arterial disease, venous insufficiency, and immunosuppression — comorbidity burdens that make unadjusted healing rates clinically meaningless as quality indicators.
A well-designed clinical data registry captures the variables needed to stratify patients appropriately: wound etiology, duration, depth, infection status, prior treatment history, and relevant comorbidities. That granularity is what transforms a raw outcome rate into a defensible quality measure.
Implementation Steps
1. Audit your current documentation practices to confirm that comorbidity burden, wound chronicity, and etiology are being captured consistently at the point of care — these are the inputs risk adjustment models depend on.
2. Work with your registry to understand how risk adjustment is applied to your submitted measures, and request benchmark reports that compare your outcomes against similar patient populations.
3. Use risk-adjusted results in conversations with hospital administrators and quality leadership to contextualize your performance — particularly if your program accepts referrals that other centers decline.
Pro Tips
Risk adjustment only works if the underlying data is complete. Incomplete comorbidity documentation doesn’t just hurt your risk model — it can also create wound care audit risk if your billing reflects high complexity that your clinical record doesn’t support. Structured registry data capture and wound care billing integrity reinforce each other.
3. Use Aggregate Registry Data to Defend Against Coverage Cuts
The Challenge It Solves
CMS and Medicare Administrative Contractors make coverage decisions based on available evidence. When that evidence is thin, coverage gets restricted. Wound care — and hyperbaric oxygen therapy in particular — has faced ongoing scrutiny from payers who question the real-world value of treatments that clinical trials haven’t definitively resolved. Claims data alone tells an incomplete story, and an incomplete story is a dangerous one when payment policy is being written.
The Strategy Explained
Registry-generated real-world outcomes data can be submitted during public comment periods and coverage review processes. CMS’s National Coverage Determination process accepts real-world evidence submissions — this is documented CMS policy. When registry data is aggregated across a large, clinically heterogeneous population and presented with appropriate methodological rigor, it carries weight that anecdote and small case series cannot.
USWR has publicly documented that its registry data has been deployed in advocacy efforts related to hyperbaric oxygen therapy coverage. That kind of policy defense requires the infrastructure of a functioning registry — years of structured data capture, consistent variable definitions, and the analytical capacity to generate credible wound care real world evidence on short notice when a coverage decision is being made.
Implementation Steps
1. Understand when your specialty’s coverage is under review. Subscribe to CMS NCD update notifications and follow your relevant specialty societies — AAWC, UHMS, APMA — for alerts about pending coverage decisions.
2. Confirm that your registry partner has the analytical infrastructure to generate aggregate outcomes reports suitable for policy submission, including appropriate statistical methodology and transparent reporting of patient population characteristics.
3. Engage with your specialty society’s advocacy committee. Individual practice participation in a registry contributes to the aggregate dataset that makes policy defense possible — your data is part of what’s in the room when coverage decisions get made.
Pro Tips
The practices that benefit most from registry-based policy defense are often the ones that contributed data years before a coverage threat materialized. You can’t build a defensible dataset in response to a proposed coverage cut. The investment has to precede the threat.
4. Leverage Outcomes Benchmarking to Drive Practice-Level Quality Improvement
The Challenge It Solves
Most wound center medical directors and quality leads want to improve outcomes but lack the comparative data to know where to focus. Internal audits reveal what’s happening in your practice, but without external benchmarks, you can’t distinguish between a performance gap and normal variation. The result is quality improvement effort that’s either misdirected or impossible to prioritize.
The Strategy Explained
Registry dashboards allow wound center medical directors and individual clinicians to compare their risk-adjusted outcomes against peer benchmarks — broken down by wound type, treatment protocol, patient subpopulation, and other clinically relevant variables. Identifying where your practice diverges from high performers on specific wound types or treatment approaches creates a roadmap for targeted quality improvement initiatives rather than diffuse, unfocused effort.
This is how chronic wound outcomes data becomes actionable. A registry that shows you’re performing above benchmark on venous leg ulcer healing rates but below benchmark on diabetic foot ulcer closure times gives you a specific clinical question to investigate — and a specific place to direct resources.
Implementation Steps
1. Establish a regular cadence for reviewing registry dashboard reports at the practice or program level — monthly or quarterly, depending on your patient volume. Assign a clinical lead responsible for interpreting benchmark comparisons.
2. When your outcomes diverge from benchmark in a specific wound category, convene a structured case review to examine whether the gap reflects documentation differences, patient population differences, or actual process variation.
3. Implement targeted protocol adjustments based on benchmark findings, then track whether subsequent registry data shows movement toward benchmark performance. This creates a closed-loop quality improvement cycle grounded in healing rate benchmarks rather than intuition.
Pro Tips
Benchmark data is most valuable when it’s specific enough to be actionable. Ask your registry partner whether benchmarks can be stratified by wound etiology, patient comorbidity profile, and treatment modality — not just overall healing rates. The more granular the comparison, the more useful the clinical signal.
5. Generate Real-World Evidence That Clinical Trials Cannot Produce
The Challenge It Solves
Clinical trials apply exclusion criteria that eliminate the majority of patients seen in wound centers: active infection, severe peripheral arterial disease, renal failure, uncontrolled diabetes. The patients who qualify for trials are systematically healthier than the patients who receive the treatments in practice. Then payers use those trial populations as the evidentiary basis for coverage decisions — creating an evidence gap that harms both patients and the manufacturers trying to demonstrate product value.
The Strategy Explained
Registry data captures outcomes in the patients who actually receive cellular and tissue-based products (CTPs), negative pressure wound therapy, and advanced dressings — including the complex patients that trials exclude and that coverage policy then also excludes. This is the wound care real world evidence that Medical Affairs, HEOR, and market access teams need and cannot generate through conventional study designs.
Both FDA and CMS have published frameworks for real-world evidence: FDA’s Real-World Evidence Program and CMS’s Coverage with Evidence Development both create pathways for registry-generated data to inform regulatory and coverage decisions. A registry with structured wound care data, consistent variable definitions, and appropriate governance is positioned to support comparative effectiveness research, external control arms for wound care trials, and post-market clinical follow-up studies.
Implementation Steps
1. If you’re a manufacturer or HEOR researcher, evaluate whether the registry’s data governance structure and variable definitions support the specific evidence questions you need to answer — skin sub comparative efficacy, CTP healing rates by wound type, NPWT outcomes in high-comorbidity populations.
2. For clinicians, understand that your structured documentation of treatment selection, application protocols, and outcomes contributes directly to the aggregate dataset that makes registry-based real-world evidence credible. Consistency in data capture is the foundation.
3. Engage with your registry partner about research collaboration opportunities — including co-investigator roles on studies using the aggregate dataset, white paper development, and support for matched cohort study designs that require large patient populations.
Pro Tips
The value of registry-generated real-world evidence depends entirely on data quality and completeness. Structured wound care data collected with consistent definitions across thousands of patients is analytically powerful. Inconsistently documented data from the same patient volume is not. The investment in data capture discipline at the point of care is what makes the downstream evidence credible.
6. Amplify Data Value Through Health Information Exchange Connectivity
The Challenge It Solves
Wound care episodes don’t happen in a single setting. A patient may receive initial wound evaluation at a hospital outpatient wound center, transition to a skilled nursing facility for ongoing care, and then continue treatment through home health. When those settings don’t share data, the episode of care is invisible as a whole — and outcomes measured at any single point are incomplete. Manual data aggregation across settings is impractical at scale and creates exactly the documentation burden that drives clinician avoidance of registries.
The Strategy Explained
A registry connected to health information exchange infrastructure can track patients longitudinally across wound centers, SNFs, and home health — unifying episode-of-care data that would otherwise be siloed. USWR has launched a wound care-specific Health Information Exchange, creating the infrastructure for this kind of cross-setting data aggregation in wound care specifically.
HIE connectivity produces more complete outcomes by capturing what happens to patients after they leave your direct care. It also reduces the manual data entry burden that makes clinicians reluctant to participate in registries in the first place — when data flows automatically from connected systems, the friction of participation drops substantially.
Implementation Steps
1. Map the typical care transitions your wound patients experience. Identify which downstream settings — SNFs, home health agencies, primary care practices — are likely to have data relevant to wound healing outcomes and episode completion.
2. Evaluate whether your registry partner has HIE connectivity that reaches those settings, and what data elements flow automatically versus require manual entry. The goal is to minimize the documentation burden on your clinical team while maximizing data completeness.
3. For multi-site groups and wound center management companies, HIE-connected registry data creates the opportunity for roster-wide outcomes reporting that aggregates performance across facilities — providing the kind of program-level evidence that administrators and quality VPs need for internal reporting and external credentialing.
Pro Tips
HIE connectivity is also a clinical workflow tool, not just a research infrastructure. When your registry can pull patient history from connected systems, your clinicians spend less time reconstructing prior treatment history at intake — which directly supports faster wound care charting and more complete clinical decision support at the point of care.
7. Turn Registry Participation Into a Research and Publication Asset
The Challenge It Solves
Wound care is a specialty that generates enormous clinical experience and relatively little published research, partly because individual practices lack the patient volumes needed for statistically meaningful studies, and partly because the field has historically been underfunded relative to its clinical burden. The result is a specialty that operates with thinner evidence than its complexity warrants — and that faces coverage scrutiny partly because the published literature can’t keep up with clinical practice.
The Strategy Explained
Large registry datasets enable retrospective studies, white papers, and peer-reviewed research that no individual practice could conduct alone. When thousands of patients’ structured data is aggregated across a registry, the statistical power to answer clinically meaningful questions becomes available: Which patient subpopulations respond best to specific CTP applications? What are the diabetic foot ulcer healing rates in patients with concurrent peripheral arterial disease? How do outcomes in registry-enrolled wound centers compare to national claims-based benchmarks?
Published registry research builds specialty credibility, supports society advocacy, and gives contributing clinicians a pathway to co-investigator status on meaningful wound care research. USWR has produced white papers and research outputs drawing on registry data — contributing to the evidence base that makes wound care outcomes defensible in policy and coverage contexts.
Implementation Steps
1. Ask your registry partner about its research program: Does it publish white papers? Has it supported peer-reviewed publications? Does it offer co-investigator opportunities for participating clinicians or practices with high data contribution?
2. Identify clinical questions that matter to your practice and patient population — questions you encounter regularly but can’t answer with your own data alone. These are candidates for registry-based research collaboration.
3. Ensure your data capture practices are consistent and complete enough to contribute meaningfully to aggregate studies. Practices with high data quality and completeness are more valuable contributors to registry research — and more likely to be included in publication acknowledgments and co-investigator roles.
Pro Tips
Research participation isn’t just an academic benefit. Published wound care outcomes data that includes your patient population and your treatment protocols is the evidence that protects your specialty’s coverage, justifies your program’s existence to hospital administration, and demonstrates value to payers who are evaluating whether to contract with your center. The research asset and the advocacy asset are the same dataset.
Putting It All Together: Your Registry Implementation Roadmap
Registry participation is not a single-use tool. The same data that keeps your practice out of MIPS penalty territory also benchmarks your outcomes, defends your specialty’s coverage, supports industry real-world evidence needs, and enables research that changes clinical guidelines. That’s the compounding return on a single investment in structured data capture.
The barrier for most wound care practices isn’t motivation. It’s the reasonable fear of adding another documentation burden on top of an already stretched clinical workflow. The right registry partner eliminates that friction through EHR integration, QCDR reporting infrastructure, HIE connectivity, and support that doesn’t require your team to become data analysts.
If your practice is treating the most complex wound patients in your region and still absorbing MIPS penalties designed for primary care, the problem isn’t your outcomes. It’s your evidence infrastructure. A specialty-specific clinical data registry is how you build that infrastructure — and how wound care, as a field, demonstrates its value before the next coverage decision gets made without your data in the room.
Explore how US Wound & Podiatry Registries can support your MIPS reporting, outcomes benchmarking, and real-world evidence needs. Learn more about our services.
Recent Comments